Blue Horseshoe Stocks: AMBA Recap & More

Adverum Biotechnologies, Inc. ADVM – Review

When we first brought ADVM into the mix on April 17th, the stock was trading for as little as 5.44, and it has never looked back. We updated readers on its performance a couple of weeks back, and once again this morning, we wanted to circle around to comment on the stock’s strong performance.

Yesterday, which marked the eighth consecutive stair-stepping session in which ADVM posted a higher low, it ran to a brand new high of 11.14. That works out to a total increase of 105% over the low we observed on the morning of our initial alert just over 6 weeks ago.Volume, especially over the last couple of weeks has also been exceptionally high. The stock is is blue skies, and we’re anxious to see where its ceiling will come.


Ambarella, Inc. AMBA

We tagged AMBA in yesterday morning’s premarket report ahead of the company’s quarterly earnings which came later during after market hours. Following a surprise beat, the stock has surged this morning, reaching a premarket high of 46.25. From our observed low of 38.06 that represents a respectable overnight swing of 22%

As you can see on the included chart, the MACD is headed for a bullish cross, and there’s still a large gap to the upside, so we will be tracking AMBA very closely on the heels of this development.

As an added bonus, we’re going to include an options idea for AMBA, the Weekly $42.50-44 Calls.


Extended Watchlist:
AMPG, BOX, ABIO, AEO,

Blue Horseshoe Stocks: LAHO Update & More

Lans Holdings, Inc. LAHO

When we brought LAHO to our readers exactly a week ago today, it was trading at .0005. After just a couple of sessions, it had registered a huge 240% move to a high of .0017. The stock then pulled back .0006 on Friday, and over another two sessions, ran back to .0014. That marks another upswing of 133% bring our four-day cumulative total to 373%

As sub-penny plays tend to do, we would expect to see LAHO continue to bounce around in this fashion. Savvy traders may yet see similar chances to profit, moving forward.


Wellness Matrix Group Inc. WMGR

WMGR is another stock that we wanted to put on our radars this morning. Regular readers of ours may recall that we occasionally include mentions of plays that are suggested to us by our followers themselves, when warranted. Such is the case with WMGR, which was brought to us by David S.

What we’ve got in WMGR is an incredibly low float stock (Just 4M shares!) that has been inching up incrementally on rising volume in recent sessions. We’re going to want to monitor in in the days and weeks ahead, as such low flot plays have the ability to make notable upswings over a relatively short time period.



NAVB & ABIO – Bottom-Bouncers

We also would like to call attention to a couple of stocks that we’ve mentioned on multiple occasions in the past, both in the biotech/pharma space. NAVB and ABIO registered as the NASDAQ’s 2nd and 4th top gainers of the day yesterday. In both cases, this followed considerable sell-offs. NAVB had been in steady decline since early April, and ABIO for the past three weeks.

We want to keep an eye on the situation on the chance that these bottom bounces were not isolated events. We’ll look for NAVB and ABIO to begin to establish higher highs and higher lows in coming sessions.


Extended Watchlist:
AMPG, AMBA, NLS, BOX, CAL,

Blue Horseshoe Stocks: GNCA Review & More

OPTIONS REVIEW

We wrapped things up on Friday by going over some of our successes for the week,. and we also provided readers with a couple of quick strike options ideas for Friday’s session itself. It should come as no surprise, given the sheer numbers of winners we routinely unearth, that both of our ideas proved to be excellent chances to finish the week on a very high note.

Here are the ideas along with the total possible gains that could have been achieved on the day.

OKTA Weekly $111-113 Calls
$111 Calls – Range: 2.20-8.62  – Max Gain: 292%
$112 Calls – Range: 1.81-7.69 – Max Gain: 325%
$113 Calls – Range: 1.28-6.20 – Max Gain: 384%

BIG 06/21 $30-32.50 Calls
$30 Calls – Range: .15-.35   – Max Gain: 133%
$32.50 Calls – Range: .05-.15 – Max Gain: 200%
____

SPY OPTIONS:
If the SPY can break 275.27, we’ll be looking at the Weekly $275.50 Calls, and if it falls below 274.50, we’ll be tracking the Weekly $274 Puts.


Genocea Biosciences, Inc. GNCA

We originally began tracking GNCA in our very first report of the new year (01/02) and we wanted to follow up with it now, five months later, as we are very impressed with where the stock has ended up. The stock actually set its 2019 low of 2.50 on January 2nd and it hasn’t looked back since.

By the end of February, the stock had doubled to five dollars, and now, it has doubled again. This morning in premarket trading, we’ve witnessed a new of 12.22 from GNCA, representing an total rise of 388% over our observed low. We’re going to be very interested to see what it’s going to do in this newfound blue-sky territory.


Extended Watchlist:
AMPG, MRTX, CYTR, AIMT, TRVN, APL, HEB, FSM, MYT, IGLD, VSTM, LODE